Lenz (LENZ) Q2 Revenue Jumps 604%
Lenz Therapeutics (NASDAQ:LENZ) reported second quarter 2025 results on July 30, revealing $5.0 million in GAAP revenue from licensing milestones, ...
Saturday, August 2, 2025
Tag: Lenz
News Summarized. Time Saved. Bite-sized news briefs for busy people. No fluff, just facts.